跳至主要内容
临床试验/NCT00811382
NCT00811382终止不适用

Clinical effecT of Heart Failure Management Via Home Monitoring With a Focus on Atrial Fibrillation (effecT)

Biotronik SE & Co. KG26 个研究点 分布在 7 个国家目标入组 163 人开始时间: 2008年5月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
163
试验地点
26
主要终点
Days Lost

研究概览

简要总结

EffecT is a prospective, randomized multicenter study to assess whether management of atrial fibrillation (AF) as well as the early optimization of cardiac resynchronization therapy (CRT) via Home Monitoring decreases mortality and morbidity compared to conventional treatment in subjects with a standard indication for CRT with Implantable Cardioverter Defibrillator (ICD) backup and AF.

详细描述

EffecT is a prospective, randomized multicenter study to assess whether management of atrial fibrillation as well as the early optimization of cardiac resynchronization therapy via Home Monitoring decreases mortality and morbidity compared to conventional treatment in subjects with a standard indication for CRT with Implantable Cardioverter Defibrillator backup (CRT-ICD) and paroxysmal or persistent AF.

300 patients with a documented history of AF will be enrolled and randomized 1:1 to standard patient management or AF management and early optimization of CRT via Home Monitoring. The patient outcome regarding days lost due to cardiovascular mortality, cardiovascular hospitalization and inappropriate ICD therapy will be documented during an observational period of 1 year.

Another 300 patients undergoing CRT-ICD implantation without a history of AF will undergo an AF evaluation during the first three months of CRT. If a patient shows an AF episode during this period, he is eligible for study inclusion. If no AF episode occurs during AF evaluation, the patient be treated as screening failure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

盲法说明

No Masking.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Indication for CRT with ICD-backup
  • Paroxysmal or persistent AF
  • Optimized HF-related medication

排除标准

  • Permanent AF
  • Contraindication for anticoagulation
  • Stroke within the last 6 weeks
  • Acute coronary syndrome within the last 2 months
  • Cardiac surgery within the last 2 months
  • Acute myocarditis
  • Severe chronic obstructive pulmonary disease (COPD)
  • Planned cardiac surgery or interventional measures within the coming 3 months
  • Dialysis dependency
  • Life expectancy < 12 months
  • Insufficient GSM (Global System for Mobile Communication)/GPRS (General Packet Radio Service)-network coverage
  • Previously implanted unipolar right atrial lead
  • Previously implanted right atrial lead with tip-ring distance > 11 mm

结局指标

主要结局

Days Lost

时间窗: 12 months

Clinical composite outcome based on the days lost due to cardiovascluar mortality, cardiovascular hospitalization and inappropriate ICD therapy during an observational period of 12 months.

次要结局

  • Progression of AF and AT/AF Burden(12 months)
  • Heart Failure Clinical Composite Score (Packer Score)(12 months)
  • Reverse Remodelling (LA Diameter, LVESV, Mitral Regurgitation)(12 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (26)

Loading locations...

相似试验

Clinical effecT of Heart Failure Management Via Home... | 临床试验